Access to the PPM Journal and newsletters is FREE for clinicians.
4 Articles in this Series
AIPM 2017 Video Highlights
Cannabinoids versus Opioids for Chronic Pain Care
Congress Seeks Consensus on Policy Coverage for Integrative Medicine
Could Systemic Lidocaine be the New Standard of Care for Pain due to Inflammation?

AIPM 2017 Video Highlights

Visual Feedback for Treating Phantom Pain

At AIPM’s 28th Annual Meeting in San Diego, Vilayanur Ramachandran, PhD, MBBS, director of the Center for Brain & Cognition at the University of California, San Diego, gave a keynote speech on the use of mirror visual feedback in reducing chronic pain.

To date, mirror visual feedback has largely been used to alleviate and manage pain in victims of stroke and amputation, said Dr. Ramachanran. Patients that experience immediate or long-lasting phantom pain, for example, may work with a practitioner to virtually view, touch, and manipulate the amputated limb through the use of a mirror and the existing limb. They may also begin to understand, with a practitioner’s guidance, why they may feel a sensation in an amputated limb when touched on the face or another part of the body.

Essentially, there are a number of psychosocial and neural connections, synesthesia in particular, that exist among patients with phantom pain, explained Dr. Ramachandran. He and his team have been researching and mapping these connections since the 1990s. They have found that regularly performed mirror visual feedback therapy in the clinical setting can relieve chronic phantom pain and restore function. In the below video, Dr. Ramachandran explains what he calls “learned pain” and provides a brief look at how non-invasive mirror feedback may further assist pain practitioners going forward.

Medical Cannabis & the Opioid Connection

Is the use of cannabis in place of opioids simply trading one problem for another, asked Mark Wallace, MD, at AIPM’s 28th Annual Meeting in San Diego. A professor of clinical anesthesiology and chair of the Pain Medicine Department at the University of California San Diego, Dr. Wallace set out to answer this question as part of his October 2017 keynote presentation on “Science, Politics, and Medicine of the Medical Cannabis for Chronic Pain.” In short, he believes the answer is “no.” In this video, he offers key takeaways for the pain management industry and goals for moving forward.  

Read the full storyon medical cannabis.


Next summary: Cannabinoids versus Opioids for Chronic Pain Care
close X